Biography

Mr. Jackson Peter Tai was appointed as our independent non-executive Director in November 2024 and is responsible for providing independent opinion and judgment to the Board. Mr. Tai has been serving as the independent non-executive director of WuXi Biologics (Cayman) Inc. (HKEX: 2269) since May 2023, the director of SEED Therapeutics, Inc. since June 2023 and the director of Novita Pharmaceuticals, Inc. since January 2023. He previously served as director of Mastercard Inc (NYSE: MA) from September 2008 to May 2023, Eli Lilly and Company (NYSE: LLY) from November 2013 to May 2023 and HSBC Holdings plc (LDN: HSBA, HKEX: 0005, NYSE: HSBC) from September 2016 to April 2023. Prior to that, Mr. Tai held various key positions in DBS Group Holdings Limited and DBS Bank Limited from 1999 to December 2007, including vice chairman, chief executive officer, chief operating officer, president and chief financial officer. Prior to that, Mr. Tai worked for 25 years in the investment banking division of J.P. Morgan & Co. Incorporated. Mr. Tai obtained a bachelor of science degree in management from Rensselaer Polytechnic Institute in the United States in June 1972 and a master’s degree in business administration from Harvard University in the United States in June 1974.